Public Meeting on the Reauthorization of Generic Drug User Fee Amendments (GDUFA) – 11/16/2021

FDA to hold public meeting to discuss proposed recommendations for reauthorization of the Generic Drug User Fee Amendments for fiscal years 2023 through 2027.